NCT03542955View on ClinicalTrials.gov

Pulse Shortwave Therapy in Cervical Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
Cervical Osteoarthritis
Interventions
DEVICE

ActiPatch

A Pulsed Shortwave Therapy Device

DRUG

Etoricoxib 60 mg

nonsteroidal anti-inflammatory drug used as standard therapy

Trial Locations (1)

Unknown

New Mazloum Hospital, Tripoli

Sponsors
All Listed Sponsors
lead

BioElectronics Corporation

INDUSTRY

NCT03542955 - Pulse Shortwave Therapy in Cervical Osteoarthritis | Biotech Hunter | Biotech Hunter